FDA Approves METRONIDAZOLE — AMICI PHARMA INC
# FDA Approves Metronidazole Generic for Amici Pharma Amici Pharma Inc. received FDA approval for its generic oral metronidazole formulation (ANDA070772), expanding the competitive landscape for this widely-used antibiotic and potentially increasing price competition in the antimicrobial treatment market. The approval enables Amici Pharma to capture market share in the established metronidazole segment, which treats bacterial and parasitic infections across multiple therapeutic applications.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day